Development of a novel AAV capsid with improved PNS tropism for treating Pompe disease by intravenous administration

被引:0
|
作者
Kevany, B. M. [1 ]
Padegimas, L. [1 ]
Miller, T. J. [1 ]
机构
[1] Abeona Therapeut Inc, Dallas, TX USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
P007
引用
收藏
页码:A21 / A21
页数:1
相关论文
共 50 条
  • [31] Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cells
    Sayroo, R.
    Nolasco, D.
    Yin, Z.
    Colon-Cortes, Y.
    Pandya, M.
    Ling, C.
    Aslanidi, G.
    GENE THERAPY, 2016, 23 (01) : 18 - 25
  • [32] Development of novel AAV variants for improved transduction of retinal microglia
    Reschigna, A.
    Murenu, E.
    Michalakis, S.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A36 - A36
  • [33] Para-Retinal Administration of AAV204, a Novel AAV Capsid for the Treatment of Inherited Retinal Dystrophies, in Non-Human Primates
    Kevany, Brian
    Kerns, Scott
    Padegimas, Linas
    MOLECULAR THERAPY, 2022, 30 (04) : 436 - 437
  • [34] Novel AAV9 Peptide Insertion Variants with Improved Tropism Tailored for Effective Retinal Gene Therapy
    Babutzka, Sabrina
    Bogedein, Jacqueline
    Buening, Hildegard
    Michalakis, Stylianos
    MOLECULAR THERAPY, 2023, 31 (04) : 591 - 591
  • [35] Isolation of Transcriptionally Active Novel AAV Capsid Sequences from Chimpanzee Tissues for Vector Development
    Xie, Jun
    Xie, Qin
    Goetzmann, Jason
    Flotte, Terry
    Gao, Guangping
    MOLECULAR THERAPY, 2009, 17 : S37 - S37
  • [36] Efficacious Androgen Hormone Administration in Combination with AAV Vector-Mediated Gene Therapy in Female Mice with Pompe Disease
    Han, Sang-oh
    Mapatano, Sweet Hope
    Li, Songtao
    Brooks, Elizabeth
    Koeberl, Dwight
    MOLECULAR THERAPY, 2017, 25 (05) : 193 - 194
  • [37] AAV204, a Novel AAV Capsid, Demonstrates Superior Macular Transduction Following Para-Retinal Administration in Non-human Primates
    Kevany, Brian
    Kerns, Scott
    Padegimas, Linas
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [38] Novel Adeno-Associated Virus (AAV) Capsid Variants for Improved Liver-Directed Gene Therapy
    Meumann, N.
    Cabanes-Creus, M.
    Ertelt, M.
    Navarro, R. N.
    Lucifora, J.
    Yuan, Q.
    Nien-Huber, K.
    Abdelrahman, A.
    Vu, X. K.
    Zhang, L.
    Franke, A. C.
    Schmithals, C.
    Vogt, A.
    Gonzalez-Carmona, M.
    Frueh, J. T.
    Ullrich, E.
    Meuleman, P.
    Talbot, S. R.
    Odenthal, M.
    Ott, M.
    Seifried, E.
    Schoeder, C. T.
    Schwaeble, J.
    Lisowski, L.
    Buening, H.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A40 - A40
  • [39] Evaluation of AAV.GMU1 Biodistribution via Intravenous Administration for Treatment of Gaucher Disease
    Ayloo, Swathi
    Chou, Shih-Ching
    Ryu, Jae
    Miller, Charles
    Bu, Jie
    Lacson, Tracy
    Gonclaves, Mariana
    Guo, Lilu
    Naas, Shelley
    Elmer, Bradford
    O'Riordan, Catherine
    Goulet, Martin
    Mueller, Christian
    Ramachandran, Shyam
    MOLECULAR THERAPY, 2024, 32 (04) : 524 - 525
  • [40] Intravenous Administration of AAV-GLA Corrects Substrate Level in the Mouse Model of Fabry Disease
    Li, Shaoyong
    Yu, Pengfei
    Li, Zhongwan
    Pang, Xiaodong
    Wang, Lijun
    Mao, Jianhua
    Lu, Zhihong
    Wu, Zhenhua
    Ye, Guo-Jie
    MOLECULAR THERAPY, 2023, 31 (04) : 771 - 772